BA
INSM icon

Bridgewater Associates’s Insmed INSM Stock Holding History

Bridgewater Associates’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.6M Buy
455,392
+159,813
+54% +$19.4M 0.2% 82
2026
Q1 		$48.3M Buy
+295,579
New +$45.4M 0.22% 78

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bridgewater Associates's INSM Position: Q2 2026 in Review

Bridgewater Associates increased its Insmed (INSM) stake by 54% in Q2 2026, buying an estimated $19.4M and bringing the position to 455,392 shares worth $48.6M. The position accounts for 0.2% of the portfolio, ranked #82.

Bridgewater Associates first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bridgewater Associates held 455,392 shares of Insmed worth $48.6M as of Q2 2026.
  • Bridgewater Associates bought 159,813 Insmed shares in Q2 2026, an estimated $19.4M.
  • Insmed made up 0.2% of Bridgewater Associates's portfolio in Q2 2026, its #82 holding.
  • Bridgewater Associates first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.